What is the treatment plan and assessment for a patient with status asthmaticus, considering their past medical history of asthma and potential complicating factors?

Status Asthmaticus: Plan and Assessment

Immediately administer high-dose nebulized beta-agonists (salbutamol 5 mg or terbutaline 10 mg) with oxygen 40-60% as the driving gas, systemic corticosteroids (prednisolone 30-60 mg orally OR hydrocortisone 200 mg IV), and maintain oxygen saturation >92%. 1, 2

Initial Assessment

Assess severity using objective measurements combined with clinical features:

Life-threatening features (any of these requires immediate ICU consideration):

• Cannot complete sentences in one breath 1
• Silent chest, cyanosis, or feeble respiratory effort 1
• Bradycardia or hypotension 1
• Exhaustion, confusion, drowsiness, or coma 1, 2
• Peak expiratory flow (PEF) <33% predicted or best 1

Severe features:

• Pulse >110 beats/min 1
• Respirations >25 breaths/min 1
• PEF <50% predicted or best 1

Critical pitfall: Patients with severe or life-threatening attacks may not appear distressed and may not exhibit all abnormalities—the presence of ANY feature should alert you. 1

Immediate Treatment Protocol

First-line therapy (administer simultaneously):

Bronchodilators:

• Nebulized salbutamol 5 mg OR terbutaline 10 mg via oxygen-driven nebulizer (40-60% oxygen) 1, 2
• Repeat every 15-30 minutes for the first hour if not improving 1
• Continue every 4 hours if improving 1

Systemic corticosteroids:

• Prednisolone 30-60 mg orally OR hydrocortisone 200 mg IV immediately 1, 2
• Continue hydrocortisone 200 mg IV every 6 hours if patient is vomiting or seriously ill 1, 2
• Maximum oral prednisolone dose: 40 mg/day 1

Oxygen therapy:

• Deliver 40-60% oxygen to maintain SpO2 >92% 1, 2
• Use oxygen as the driving gas for all nebulizer treatments 1

Monitoring at 15-30 minutes post-treatment:

Measure PEF and reassess clinical status 1:

If PEF remains <50% or severe features persist:

• Add ipratropium bromide 0.5 mg to nebulized beta-agonist 1, 2
• Repeat ipratropium every 6 hours until improvement starts 1
• Consider IV/subcutaneous bronchodilators if inadequate response 1, 3

If life-threatening features present:

• Add ipratropium 0.5 mg immediately 1, 2
• Consider IV aminophylline 250 mg over 20 minutes OR subcutaneous/IV terbutaline 250 μg over 10 minutes 1, 2
• Caution: Reduce aminophylline loading dose if patient has taken theophylline within 24 hours 1

Escalation and ICU Transfer

Transfer to ICU with a physician prepared to intubate if: 1, 2

• Deteriorating PEF despite maximal treatment
• Worsening or persistent hypoxia or hypercapnia
• Exhaustion, feeble respirations
• Confusion, drowsiness, or coma
• Respiratory or cardiac arrest

Absolute contraindications:

• Never administer sedatives in acute asthma—sedation is absolutely contraindicated even in agitated patients 2
• Do not perform percussive physiotherapy 2

Antibiotic Considerations

Do NOT routinely prescribe antibiotics. 2 Antibiotics are unhelpful in acute asthma unless bacterial infection is confirmed. 2 If patient has purulent sputum, consider antibiotics only after confirming bacterial pneumonia. 1, 2

Hospital Admission Criteria

Admit if any of the following: 1

• Any life-threatening features present
• Any features of acute severe asthma persist after initial treatment
• PEF <33% predicted or best after treatment

Lower threshold for admission if: 1

• Attack occurs in afternoon or evening
• Recent nocturnal symptoms or hospital admission
• Previous severe attacks
• Poor social circumstances or inability to assess own condition

Discharge Criteria

Do NOT discharge until ALL criteria met: 1, 2

• PEF >75% of predicted or personal best
• PEF diurnal variability <25%
• Stable on discharge medications for 24 hours
• Inhaler technique verified and recorded
• No nocturnal symptoms
• Treatment includes oral corticosteroids, inhaled corticosteroids, and bronchodilators 1
• Patient has own PEF meter and written self-management plan 1
• GP follow-up arranged within 1 week 1
• Clinic follow-up arranged within 4 weeks 1

Ongoing Monitoring During Hospitalization

• Repeat PEF measurement 15-30 minutes after each treatment 1
• Maintain continuous oximetry targeting SpO2 >92% 1, 2
• Chart PEF before and after inhaled beta-agonists, minimum 4 times daily 1
• Obtain chest radiograph if patient remains ill despite intensive treatment to exclude pneumothorax 1

Common Pitfalls to Avoid

Underuse of corticosteroids is a major factor contributing to asthma deaths—always administer systemic steroids immediately. 1

Failure to assess severity objectively through PEF or FEV1 measurements leads to underestimation of severity. 1, 4

Delay in treatment can be fatal—regard each emergency consultation as acute severe asthma until proven otherwise. 1

Premature discharge before achieving stability increases risk of subsequent death (14% mortality at 3 years post-respiratory failure). 5, 6